Maxiclens Chlorhexidine Gluconate Liquid Solution, 4% Solution
NDC Package 0404-0221-04
Package Information
Maxiclens Chlorhexidine Gluconate Liquid Solution, 4% (chlorhexidine gluconate) solution is a medication used along with regular tooth brushing/flossing to treat gingivitis, a gum disease that causes red, swollen, and easily bleeding gums. This formulation utilizes a solution delivery system. Marketed by Henry Schein, Inc., this product is identified by NDC 0404-0221 and is authorized under FDA application NDA019258.
Identification & Billing
- RxCUI: 211365 - chlorhexidine gluconate 4 % Medicated Liquid Soap
- RxCUI: 211365 - chlorhexidine gluconate 40 MG/ML Medicated Liquid Soap
- RxCUI: 211365 - chlorhexidine gluconate 4 % Medicated Surgical Scrub
- RxCUI: 2630838 - Maxiclens 4 % Medicated Liquid Soap
- RxCUI: 2630838 - chlorhexidine gluconate 40 MG/ML Medicated Liquid Soap [Maxiclens]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0404 - Henry Schein, Inc.
- 0404-0221 - Maxiclens Chlorhexidine Gluconate Liquid Solution, 4%
- 0404-0221-04 - 473 mL in 1 BOTTLE
- 0404-0221 - Maxiclens Chlorhexidine Gluconate Liquid Solution, 4%
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0404-0221-04 identifies a specific commercial package of 473 ml in 1 bottle of Maxiclens Chlorhexidine Gluconate Liquid Solution, 4%, a human over the counter drug labeled by Henry Schein, Inc.. This solution is formulated for topical use and contains chlorhexidine gluconate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Henry Schein, Inc. on November 17, 2021. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used along with regular tooth brushing/flossing to treat gingivitis, a gum disease that causes red, swollen, and easily bleeding gums. Chlorhexidine belongs to a class of drugs known as antimicrobials. It works by decreasing the amount of bacteria in the mouth, helping to reduce swelling and redness of the gums and bleeding when you brush.
How is this Henry Schein, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00404022104. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.